New York Attorney General probes Shkreli over antitrust concerns
pic thx to david goehring flickr creative commons For the second time in a week, Turing Pharmaceuticals is facing anti-trust scrutiny. The New York State Attorney General wants to know more about a...
View ArticleHow High? The backlash over prescription drug prices rolls onward
pic thx to david goehring flickr creative commons The backlash over prescription drug prices shows no sign of abating. Just take a look at a few developments over the past several days. Hillary Clinton...
View ArticleMartin Shkreli may get competition for his pricey drug, after all
thx to william warby on flickr creative commons Thanks to a compounding pharmacy, Martin Shkreli’s company may no longer have a lock on the market for its pricey anti-infective drug Daraprim. A...
View ArticleSenators ask FTC to investigate saline suppliers over shortages and pricing
thx to somegeekintn flickr creative commons Four US Senators have asked the Federal Trade Commission to investigate whether suppliers of saline solution have illegally inflated prices in order to...
View ArticlePharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Valeant,...
pic thx to mick kelly on flickr creative commons Good morning, folks. A happy, shiny sun is hovering over the Pharmalot campus where, after a brief road trip, we have resumed our usual ritual of...
View ArticleFTC raises anticompetitive concerns about FDA naming proposal for biosimilars
What’s in a name? A contentious debate over identifying biosimilars is sparking concern from antitrust regulators. These drugs are designed to emulate expensive biologics and are forecast to save...
View ArticleWill a compounded version of Martin Shkreli’s drug really make a difference?
thx to william warby on flickr creative commons When a compound pharmacy trumpeted plans last month to sell a cheap version of Martin Shkreli’s pricey anti-infective drug, the move was greeted with...
View ArticlePharmalot.. Pharmalittle.. Good Morning.. Catching up on Valeant, Smart Drugs...
coffee thx to chichacha on flickr creative commons Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? After all, consider the alternatives....
View ArticleSenators probe Valeant and Shkreli over drug prices, while House Dems form a...
pic thx to images money on flickr creative commons Consumers are angry over prescription drug costs and now all three branches of the federal government are trying to take action. A pair of US Senators...
View ArticleSupreme Court asked to review Namenda product switching case
pic thx to david on flickr creative commons The US Supreme Court is weighing a request from Allergan to rule on whether drug companies can pull a medication from the market as generic competition looms...
View ArticleNew York Attorney General probes Shkreli over antitrust concerns
pic thx to david goehring flickr creative commons For the second time in a week, Turing Pharmaceuticals is facing anti-trust scrutiny. The New York State Attorney General wants to know more about a...
View ArticleHow High? The backlash over prescription drug prices rolls onward
pic thx to david goehring flickr creative commons The backlash over prescription drug prices shows no sign of abating. Just take a look at a few developments over the past several days. Hillary Clinton...
View ArticleMartin Shkreli may get competition for his pricey drug, after all
thx to william warby on flickr creative commons Thanks to a compounding pharmacy, Martin Shkreli’s company may no longer have a lock on the market for its pricey anti-infective drug Daraprim. A...
View ArticleSenators ask FTC to investigate saline suppliers over shortages and pricing
thx to somegeekintn flickr creative commons Four US Senators have asked the Federal Trade Commission to investigate whether suppliers of saline solution have illegally inflated prices in order to...
View ArticlePharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Valeant,...
pic thx to mick kelly on flickr creative commons Good morning, folks. A happy, shiny sun is hovering over the Pharmalot campus where, after a brief road trip, we have resumed our usual ritual of...
View ArticleFTC raises anticompetitive concerns about FDA naming proposal for biosimilars
What’s in a name? A contentious debate over identifying biosimilars is sparking concern from antitrust regulators. These drugs are designed to emulate expensive biologics and are forecast to save...
View ArticleWill a compounded version of Martin Shkreli’s drug really make a difference?
thx to william warby on flickr creative commons When a compound pharmacy trumpeted plans last month to sell a cheap version of Martin Shkreli’s pricey anti-infective drug, the move was greeted with...
View ArticlePharmalot.. Pharmalittle.. Good Morning.. Catching up on Valeant, Smart Drugs...
coffee thx to chichacha on flickr creative commons Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? After all, consider the alternatives....
View ArticleSenators probe Valeant and Shkreli over drug prices, while House Dems form a...
pic thx to images money on flickr creative commons Consumers are angry over prescription drug costs and now all three branches of the federal government are trying to take action. A pair of US Senators...
View ArticleSupreme Court asked to review Namenda product switching case
pic thx to david on flickr creative commons The US Supreme Court is weighing a request from Allergan to rule on whether drug companies can pull a medication from the market as generic competition looms...
View Article
More Pages to Explore .....